Department of Biochemistry and Molecular Biology, School of Life Sciences, Central South University, Changsha, China.
Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
Front Endocrinol (Lausanne). 2021 Mar 22;12:598656. doi: 10.3389/fendo.2021.598656. eCollection 2021.
Pheochromocytoma, as a neuroendocrine tumor with the highest genetic correlation in all types of tumors, has attracted extensive attention. Von Hipper Lindau (VHL) has the highest mutation frequency among the genes associated with pheochromocytoma. However, the effect of VHL on the proteome of pheochromocytoma remains to be explored. In this study, the VHL knockdown (VHL-KD) PC12 cell model was established by RNA interference (shRNA). We compared the proteomics of VHL-KD and VHL-WT PC12 cell lines. The results showed that the expression of 434 proteins (VHL shRNA/WT > 1.3) changed significantly in VHL-KD-PC12 cells. Among the 434 kinds of proteins, 83 were involved in cell proliferation, cell cycle and cell migration, and so on. More importantly, among these proteins, we found seven novel key genes, including Connective Tissue Growth Factor (CTGF), Syndecan Binding Protein (SDCBP), Cysteine Rich Protein 61 (CYR61/CCN1), Collagen Type III Alpha 1 Chain (COL3A1), Collagen Type I Alpha 1 Chain (COL1A1), Collagen Type V Alpha 2 Chain (COL5A2), and Serpin Family E Member 1 (SERPINE1), were overexpressed and simultaneously regulated cell proliferation and migration in VHL-KD PC12 cells. Furthermore, the abnormal accumulation of HIF2α caused by VHL-KD significantly increased the expression of these seven genes during hypoxia. Moreover, cell-counting, scratch, and transwell assays demonstrated that VHL-KD could promote cell proliferation and migration, and changed cell morphology. These findings indicated that inhibition of VHL expression could promote the development of pheochromocytoma by activating the expression of cell proliferation and migration associated genes.
嗜铬细胞瘤作为所有肿瘤中遗传相关性最高的神经内分泌肿瘤,引起了广泛关注。von Hippel-Lindau(VHL)基因是与嗜铬细胞瘤相关的基因中突变频率最高的基因。然而,VHL 对嗜铬细胞瘤蛋白质组的影响仍有待探索。本研究通过 RNA 干扰(shRNA)建立了 VHL 敲低(VHL-KD)PC12 细胞模型。我们比较了 VHL-KD 和 VHL-WT PC12 细胞系的蛋白质组学。结果表明,在 VHL-KD-PC12 细胞中,有 434 种蛋白质的表达(VHL shRNA/WT > 1.3)发生了显著变化。在这 434 种蛋白质中,有 83 种参与细胞增殖、细胞周期和细胞迁移等过程。更重要的是,在这些蛋白质中,我们发现了 7 个新的关键基因,包括结缔组织生长因子(CTGF)、连接蛋白结合蛋白(SDCBP)、富含半胱氨酸蛋白 61(CYR61/CCN1)、III 型胶原α 1 链(COL3A1)、I 型胶原α 1 链(COL1A1)、V 型胶原α 2 链(COL5A2)和丝氨酸蛋白酶抑制剂家族 E 成员 1(SERPINE1),它们在 VHL-KD PC12 细胞中过表达并同时调节细胞增殖和迁移。此外,VHL-KD 导致的 HIF2α 异常积累在缺氧时显著增加了这 7 个基因的表达。此外,细胞计数、划痕和 Transwell 实验表明,VHL-KD 可促进细胞增殖和迁移,并改变细胞形态。这些发现表明,抑制 VHL 表达可通过激活与细胞增殖和迁移相关的基因表达促进嗜铬细胞瘤的发生。